CURRENT USE AND QUESTIONS CONCERNING INTRAVESICAL BLADDER CANCER GROUP FOR SUPERFICIAL BLADDER CANCER
- 1 February 2000
- journal article
- review article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 27 (1), 137-146
- https://doi.org/10.1016/s0094-0143(05)70241-x
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Additional bacillus calmette-guérin therapy for recurrent transitional cell carcinoma after an initial complete responseUrology, 1997
- Management of Stage T1 Superficial Bladder Cancer with Intravesical Bacillus Calmette-Guerin TherapyJournal of Urology, 1992
- Bacillus Calmette-Guerin Therapy for High Risk Stage T1 Superficial Bladder CancerJournal of Urology, 1992
- Long-Term Followup of Patients Treated With 1 or 2, 6-Week Courses of Intravesical Bacillus Calmette-Guerin: Analysis of Possible Predictors of Response Free of TumorJournal of Urology, 1990
- The Response of Patients with Superficial Bladder Cancer to a Second Course of Intravesical Bacillus Calmette-GuerinJournal of Urology, 1990
- Bladder Tumors Invading the Lamina propria (Stage A/Tl): Influence of Endovesical Bacillus Calmette-Guérin Therapy on Recurrence and ProgressionEuropean Urology, 1989
- A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer.Journal of Clinical Oncology, 1987
- Risks and Benefits of Repeated Courses of Intravesical Bacillus Calmette-guerin Therapy for Superficial Bladder CancerJournal of Urology, 1987
- Two Courses of Intravesical Bacillus Calmette-Guerin for Transitional Cell Carcinoma of the BladderJournal of Urology, 1986
- The Significance of Lamina Propria Invasion on the Prognosis of Patients with Bladder TumorsJournal of Urology, 1980